The Can-GARD Scientific Advisory Board (SAB) was created to ensure our mandate is followed by providing expert advice, recommendations, and guidance to our strategic plans to help shape our vision and direction.

The SAB membership includes six of Canada’s world renowned respected leaders in the rare disease field:

Bernard Brais, M.D.C.M., M.Phil., PhD, FRCP(C)
Professor, Department of Neurology and Neurosurgery
Division of Neurology
Faculty of Medicine, McGill University

Kym Boycott, MD, PhD
Medical Geneticist and Senior Scientist,
Children’s Hospital of Eastern Ontrario (CHEO) Research Institute
Clinical Geneticist, Department of Genetics, CHEO
Associate Professor, Department of Pediatrics, Faculty of Medicine,
University of Ottawa
Co-Chair, International Rare Disease Research Consortium (IRDiRC),
Diagnostics Committee

Cheryl Rockman-Greenberg, MD, CM, FRCPC, FCCMG
Director, Metabolic Service
Clinical Geneticist, Program in Genetics and Metabolism
Distinguished Professor, Department of Pediatrics and Child Health and the Department of Biochemistry and Medical Genetics, University of Manitoba

Scot Leary, PhD
Associate Professor
Department of Biochemistry
University of Saskatchewan

Stephen Scherer, PhD
Director, The Centre for Applied Genomics
Director, McLaughlin Centre
Senior Scientist, SickKids Research Insitute
Professor, Department of Molecular Genetics, University of Toronto

Elizabeth M. Simpson, BSc, M.Sc., PhD
Senior Scientist, Centre for Molecular Medicine and Therapeutics (CMMT)
Scientist, Child & Family Research Institute
Professor, Department of Medical Genetics
Associate Member, Department of Psychiatry
Associate Member, Department of Ophthalmology & Visual Sciences